Factor

An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

factor

n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

factor

1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.

2 an institution to whom a company assigns its book debts (see FACTORING).

3 in Scotland a landlord or superior's agent.

Collins Dictionary of Law © W.J. Stewart, 2006

Mentioned in

References in periodicals archive

VBI-1901 is administered intradermally and is adjuvanted with granulocyte-macrophage colony-stimulating factor (GM-CSF), a potent adjuvant that mobilizes dendritic cell function.

VBI Vaccines doses first patient in Part B of Phase 1/2a study of VBI-1901

United Kingdom-based GSK has commenced a phase III clinical development programme with otilimab, an investigational anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, it was reported yesterday.

GSK starts phase III clinical development programme with otilimab

G-CSF (granulocyte-colony stimulating factor), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream.

First Subjects Dosed In Phase 1 Trial Of Stem Cell Mobilization Factor

We evaluated the concentrations of a select panel of cytokines, including innate immune mediators (interferon [IFN]-[gamma], interleukin [IL]-15, IFN-P); inflammatory factors (IL-6, IL-18, soluble intercellular adhesion molecule 1 [sICAM-1]); chemokines (CC-motif chemokine ligand [CCL] 3, CCL-4, CXC-motif chemokine ligand [CXCL] 1, CXCL-8, CXCL-10); hematopoietic factors (granulocyte colony-stimulating factor [G-CSF], granulocyte-macrophage colony-stimulating factor); the angiogenic factor vascular endothelial growth factor A (VEGF-A); and proteases (matrix metalloproteinase [MMP]-2, MMP-9).

Peripheral Plasma and Semen Cytokine Response to Zika Virus in Humans

The protective effect of granulocyte colony-stimulating factor on endometrium and ovary in a rat model of diabetes mellitus.

Bone Marrow Stromal Cells with the Granulocyte Colony-Stimulating Factor in the Management of Chemotherapy-Induced Ovarian Failure in a Rat Model

LOW-DOSE TREATMENT with plerixafor, a CXC chemokine receptor 4 antagonist, was well tolerated and markedly improved severe presentations of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome in three patients who could not receive granulocyte colony-stimulating factor (G-CSF) therapy.

Plerixafor produced dramatic responses in severe WHIM syndrome

Identification and characterization of receptors for granulocyte colony-stimulating factor on human placenta and trophoblastic cells.

Comparing the Impact of Autologous Platelet-rich Plasma and Granulocyte Colony Stimulating Factor on Pregnancy Outcome in Patients with Repeated Implantation Failure

TJM2 is a humanised immunoglobulin G1 (IgG1) targeting granulocyte-macrophage colony-stimulating factor (GM-CSF) and is the first candidate from I-Mab's innovative proprietary pipeline to be approved for clinical trials by the FDA.

US FDA approves I-Mab's IND for TJM2

Keywords: Neonatal sepsis, neutropenia, Granulocyte Colony-Stimulating Factor.

Granulocyte-colony stimulating factor in neonatal sepsis with leukopenia: A prospective cohort study

Pegfilgrastim, a granulocyte colony-stimulating factor (G-CSF) receptor agonist, is used to stimulate bone marrow to produce more neutrophils in order to decrease the incidence of infection in patients undergoing chemotherapy.

Mundipharma Acquires Biosimilars Development Company Cinfa Biotech

Objective: To determine the effectiveness of granulocyte colony-stimulating factor (G-CSF) in the reduction of atherosclerotic lesions in a rabbit animal model.

EFFECTIVENESS OF GRANULOCYTE COLONY-STIMULATING FACTOR IN REDUCTION OF ATHEROSCLEROTIC LESIONS IN RABBIT

Baby developed severe neutropenia at DOL 2, with absolute polymorphonuclear count <500 [micro]/L, and was started with granulocyte colony-stimulating factor. Due to favorable clinical evolution in addition to negative blood culture, Ampicillin-Gentamicin were discontinued at DOL 5.

Trichosporon asahii late onset sepsis in an extremely low birth weight infant